4G Clinical raises USD5m in Series A1 financing led by Schooner Capital.
BANKING AND CREDIT NEWS-October 24, 2016-4G Clinical raises USD5m in Series A1 financing led by Schooner Capital
(C)2016 M2 COMMUNICATIONS http://www.m2.com
4G Clinical has raised USD5 million in Series A1 financing led by Boston-based Schooner Capital, the company said.
Combined with USD2.5 million that was announced in January, this latest round of financing brings 4G's Series A funding total to USD7.5 million. The additional funding will be used to support company operations, further product development and support early marketing of Prancer, the company's fourth generation Randomization and Trial Supply Management (RTSM) offering.
4G Clinical is a full service RTSM company focused on simplifying and accelerating the drug development process. The company was founded in October, 2015, to develop a service offering centered around a 4th generation Randomization and Trial Supply Management (RTSM) system, Prancer. Headquartered in the heart of the Boston biotech corridor, in Wellesley, MA, 4G Clinical has facilities and staff located in the US and Europe, and is poised to offer global expertise and advisory services to pharmaceutical companies and contract research organizations.
Founded in 1971, Schooner Capital is a Boston-based private investment firm engaged in venture capital, growth equity and alternative asset investments. Schooner has no outside limited partners and approaches all investments with a long-term perspective.
((Comments on this story may be sent to firstname.lastname@example.org))